Roadmap To U.S. Drug Manufacturing: Outsource And Build At Home

SourceOutsourced Pharma
Date Published06/17/2020
Author NameLouis Garguilo
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Nexus Pharmaceuticals Inc.
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):77
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2022
Capital investment ($):250
Country(ies) from which reshored:India
City reshored to:Pleasant Prairie
State(s) reshored to:WI
If relevant, work nearshored to:-
Product(s) reshoredinjectable pharmaceuticals
What non-domestic negative factors made offshoring less attractive?Quality/rework/warranty, Supply chain interruption risk/Natural disaster risk/Political instability , Travel cost/time
What domestic positive factors made reshoring more attractive?Impact on domestic economy, Skilled workforce availability/training
Find Reshoring Articles